Drug profile · INN
micafungin sodium
MICAFUNGIN SODIUM
micafungin sodium (MICAFUNGIN SODIUM) is a 1,3-beta-glucan synthase inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — micafungin sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 4
- Data quality
- 0.89
Quick answer
micafungin sodium (MICAFUNGIN SODIUM) is a 1,3-beta-glucan synthase inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
1,3-beta-glucan synthase inhibitor
Primary target: 1,3-beta-glucan synthase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is micafungin sodium?
micafungin sodium (MICAFUNGIN SODIUM) is a 1,3-beta-glucan synthase inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for micafungin sodium?
MICAFUNGIN SODIUM is a marketed brand name for micafungin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of micafungin sodium?
micafungin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.